𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiarrhythmic drug development—illusion and disillusion?

✍ Scribed by Michael J. A. Walker

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
35 KB
Volume
55
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Better antiarrhythmics? Development of a
Better antiarrhythmics? Development of antiarrhythmic drugs selective for ischaemia-dependent arrhythmias
✍ Allen I. Bain; Terrance D. Barrett; Gregory N. Beatch; David Fedida; Eric S. Hay 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB

RSD1000 is one example of a series of compounds synthesized by Nortran Pharmaceuticals, Inc., to provide selective protection against arrhythmias due to myocardial ischaemia and so providing better therapeutic indices than existing drugs. RSD1019 is an analogue of RSD1000, whose therapeutic indices

Antiarrhythmic drugs and reperfusion
Antiarrhythmic drugs and reperfusion
📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 321 KB

Darucainide (B) is a new, orally available class IBagent and was shown to be highly effective in experimental arrhythmias. We initially studied 12 pts (group A: 40-68 years, 6 men) with very frequent, repetitive and refractory (< 2 agents) ventricular premature beats (5600 VPB/h, median: 18.552 VPDs